Skip navigation
中文
English
DSpace
CRIS
Home
Organizations
Researchers
Research Outputs
Explore by
Organizations
Researchers
Research Outputs
Academic & Publications
Help
Sign in
中文
English
NTU Scholars
Research Outputs
Browsing by Author
Hung C.-F.
or enter first few letters:
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 20 of 69
next >
Issue Date
Title
Author(s)
Source
scopus
WOS
Fulltext/Archive link
2010
Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
Shieh J.-M.; TUR-FU HUANG
; Hung C.-F.; Chou K.-H.; Tsai Y.-J.; Wu W.-B.
British Journal of Pharmacology
53
52
2006
Biochemistry examinations and health disorder evaluation of Taiwanese living near incinerators and with low serum PCDD/Fs levels
Chen H.-L.; Su H.-J.; YUE-LIANG GUO
; Liao P.-C.; Hung C.-F.; Lee C.-C.
Science of the Total Environment
29
23
2000
Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines
CHIEN-HUNG CHEN
; Wang T.-L.; Hung C.-F.; Pardoll D.M.; Wu T.-C.
Vaccine
86
70
2001
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
Hung C.-F.; WEN-FANG CHENG
; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
Cancer Research
0
2002
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
WEN-FANG CHENG
; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.
Human Gene Therapy
111
103
2005
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
Cheng W.-F.; Hung C.-F.; CHI-AN CHEN
; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C.
Vaccine
26
24
2005
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
WEN-FANG CHENG
; Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C.
Vaccine
26
24
2005
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
Cheng W.-F.; Hung C.-F.; Chen C.-A.; CHIEN-NAN LEE
; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; Hsieh C.-Y.; Wu T.-C.
Vaccine
24
2005
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
Cheng W.-F.; Hung C.-F.; Chen C.-A.; Lee C.-N.; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; CHANG-YAO HSIEH
; Wu T.-C.
Vaccine
26
24
2004
Comparison of HPV DNA vaccines employing intracellular targeting strategies
Kim J.W.; Hung C.-F.; Juang J.; He T.; Kim T.W.; Armstrong D.K.; Pai S.I.; PEI-JER CHEN
; Lin C.-T.; Boyd D.A.; Wu T.-C.
Gene Therapy
89
2015
The differential effects of a selective kappa-opioid receptor agonist, U50488, in Guinea pig heart tissues
Hung C.-F.; Li H.-J.; Chang H.-H.; Lee G.-A.; MING-JAI SU
BioMed Research International
0
1998
Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues
Hung C.-F.; Wu M.-H.; Tsai C.-H.; Chu S.-H.; Chi J.-F.; MING-JAI SU
Life Sciences
20
14
1998
Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues
Hung C.-F.; MEI-HWAN WU
; Tsai C.-H.; Chu S.-H.; Chi J.-F.; Su M.-J.
Life Sciences
20
14
2001
Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand
Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG
; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
Cancer Research
0
2000
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
CHIEN-HUNG CHEN
; Wang T.-L.; Hung C.-F.; Yang Y.; Young R.A.; Pardoll D.M.; Wu T.-C.
Cancer Research
290
2001
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
WEN-FANG CHENG
; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
Journal of Virology
72
60
2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
WEN-FANG CHENG
; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.
Journal of Immunology
62
55
2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments
WEN-FANG CHENG
; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.
Human Gene Therapy
61
59
2001
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG
; He L.; Slater L.A.; Ling M.; Wu T.-C.
Gene Therapy
106
94
2004
Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin
Hsieh C.-J.; Kim T.W.; Hung C.-F.; Juang J.; Moniz M.; Boyd D.A.K.; He L.; Chen P.-J.; CHIEN-HUNG CHEN
; Wu T.-C.
Vaccine
57
55